PPD offers a broad range of early development services, Phase I clinical trial services and nonclinical consulting.
Extensive knowledge of hematology and oncology research, vast capabilities and experience with feasibility studies and a large investigator network.
PPD's Phase I Clinic conducts clinical studies to determine how new medicines act in the bodies of healthy volunteers.
Get information about PPD posted on industry websites and publications.
PPD has been recognized for excellence in clinical research for the eighth consecutive year by pharmaceutical and biotech executives surveyed for Life Science Leader magazine’s 2019 CRO Leadership Awards.
01 May 2019
PPD was named the winner of the CRO Quality Award from the Association of Clinical Research Professionals (ACRP) and The Avoca Group during the recent ACRP annual conference in Nashville, Tennessee.
25 Apr. 2019
Optimal Research, a service of PPD’s Accelerated Enrollment Solutions (AES) business unit, was named the top clinical trial network at the 12th annual Vaccine Industry Excellence (ViE) Awards.
23 Apr. 2019
PPD, a leading global contract research organization, has been named to Forbes magazine’s 2019 list of America’s Best Large Employers, marking the second consecutive year the company was selected.
17 Apr. 2019
PPD announced today it has been named to Training magazine’s 2019 Training Top 125 list recognizing excellence in employee learning and development.
27 Feb. 2019
PPD and Happy Life Tech (HLT) of China have signed an exclusive agreement to develop a distinctive service offering for the China drug-development market.
20 Feb. 2019
PPD, a leading global contract research organization dedicated to improving health, has been named to Forbes magazine’s 2019 list of America’s Best Employers for Diversity.
15 Jan. 2019
Senior Manager, Corporate CommunicationsPPD
Tel: +1 919 456 4425
Manager, Corporate CommunicationsPPD
Tel: +1 919 456 6389
© 2019 Pharmaceutical Product Development, LLC. All rights reserved.